After five months of testing on patients with nonsegmental vitiligo, the researchers found that MT1 therapy coupled with NBUV-B phototherapy produced statistically significant superior and faster repigmentation compared with monotherapy, especially in the face and upper extremities [7, 8]
MedlinePlus also lists nausea, vomiting, diarrhea, abdominal pain, constipation, heartburn, and burping among side effects patients may experience
However, and like most grey market peptides, CJC-1295 did not succeed its clinical trial, and hence never became an official drug
Call and speak to a compassionate and knowledgeable admissions navigator who can answer your questions, check your coverage, and explain your treatment options
x Na M.W
What is the annual incidence of NAION in individuals over 50